Clinical trial

Cerebellum-based Imaging Neural Markers for Antipsychotic Response

NCT07483294

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-11-01

PhasePHASE4

Study timeline

Study start (actual)2025-11-01Date precision: day

Registry last updated2026-05-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Psychosis; Acuteunresolved

Interventions

risperidoneDRUG · verified · RxNorm: risperidone

aripiprazoleDRUG · verified · RxNorm: aripiprazole

Sponsors & collaborators

Northwell Healthlead sponsor

National Institute of Mental Health (NIMH)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07483294 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.